Péter Mátyus

Title: Péter Mátyus: Innovator in Antiarrhythmic Compounds

Introduction

Péter Mátyus is a notable inventor based in Budapest, Hungary. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antiarrhythmic compounds. With a total of 3 patents to his name, Mátyus continues to push the boundaries of medical innovation.

Latest Patents

His latest patents focus on novel, antiarrhythmically active phenoxyalkylamine derivatives that possess a double point of attack. One of the key inventions relates to new phenoxyalkylamine derivatives of the formula (1) N-([1,4]benzodioxan-2-ylmethyl)-N-(3-chloro-1-propyl)-amine. This invention also includes R-2-[3-([1,4]benzodioxan-2-ylmethylamino)-1-propyl]-3(2H)-pyridazinone of formula (1) and S-2-[3-([1,4]benzodioxan-2-ylmethylamino)-1-propyl]-3(2H)-pyridazinone of formula (2). Additionally, the invention encompasses acid-addition salts and pharmaceutical compositions containing these compounds. The compounds exhibit α- and β-adrenoceptor antagonistic effects and urogenital selectivity, making them useful for treating benign prostate hyperplasia.

Career Highlights

Throughout his career, Mátyus has worked with various organizations, including Gyógyszerkutató Intézet Kft. His work has been instrumental in advancing the understanding and treatment of cardiovascular conditions.

Collaborations

He has collaborated with notable colleagues such as Antal Simay and Ildikó Varga, contributing to a rich exchange of ideas and innovations in the pharmaceutical field.

Conclusion

Péter Mátyus stands out as a significant figure in the realm of pharmaceutical innovation, particularly in the development of antiarrhythmic compounds. His contributions continue to impact the medical community positively.